Felbamate for infantile spasms syndrome resistant to first-line treatments.
Blandine Dozières-PuyravelHala NasserVanina BellavoineAdina IleaCatherine DelanoeStėphane AuvinPublished in: Developmental medicine and child neurology (2019)
N-methyl-d-aspartate receptors with felbamate controlled epileptic spasms in eight infants resistant to first-line treatment should be targeted.
Keyphrases